CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants

Cai Liao1, Zhen-Wei He2, Rui Yu1

  • 1Department of Clinical Pharmacology, School of Pharmacy, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, Liaoning, China.

Archives of Toxicology
|March 18, 2024
PubMed

Insights

Circular RNAs (circRNAs) regulate gene expression and are involved in lung injury development. This review explores circRNAs as potential biomarkers and therapeutic targets for lung damage caused by various toxicants.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Lung injury presents a significant health challenge demanding novel therapeutic strategies and biomarkers.
  • Circular RNAs (circRNAs) are eukaryotic non-coding RNAs forming closed loops, acting as crucial gene regulators.
  • Their roles in transcription, translation, and sponging miRNAs/proteins highlight their involvement in biological processes.

Purpose of the Study:

  • To review the biogenesis, properties, and functions of circRNAs.
  • To discuss the relationship between circRNAs and lung injury induced by pulmonary toxicants.
  • To explore the potential of circRNAs as biomarkers and therapeutic targets for lung injury.

Main Methods:

  • Literature review focusing on circRNAs and lung injury.
  • Analysis of circRNA roles in response to pulmonary toxicants like SARS-CoV-2, drug abuse, PM2.5, and cigarette smoke.
  • Synthesis of current knowledge on circRNA biogenesis, function, and expression patterns.

Main Results:

  • CircRNAs play significant roles in the development, progression, and therapy of lung injury.
  • Expression patterns of various circRNAs are altered in lung injury models.
  • Several circRNAs show potential as biomarkers for detecting and monitoring lung injury.

Conclusions:

  • CircRNAs are implicated in the molecular mechanisms of lung injury.
  • Understanding circRNA functions offers new avenues for therapeutic interventions.
  • Further research into circRNAs may yield novel treatment targets for lung injury.